Efficacy and safety of pyronaridine-artesunate (Pyramax(®)) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia

BACKGROUND: Declining efficacy of chloroquine for the treatment Plasmodium vivax malaria has been reported in different endemic settings in Ethiopia. This highlights the need to assess alternative options for P. vivax treatment with artemisinin-based combination therapy, such as pyronaridine-artesun...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Hussein, Sime, Heven, Hailgiorgis, Henok, Chernet, Melkie, Alebachew, Mihreteab, Solomon, Hiwot, Assefa, Gudissa, Haile, Mebrahtom, Girma, Samuel, Bekele, Worku, Tasew, Geremew, Gidey, Bokretsion, Commons, Robert J., Assefa, Ashenafi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805271/
https://www.ncbi.nlm.nih.gov/pubmed/36587210
http://dx.doi.org/10.1186/s12936-022-04422-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805271/
https://www.ncbi.nlm.nih.gov/pubmed/36587210
http://dx.doi.org/10.1186/s12936-022-04422-0

Ejemplares similares